ATOS Stock Price
Atossa Therapeutics, Inc.
ATOS stock price is $2.78 (+8.59% on the day), giving Atossa Therapeutics, Inc. a market cap of $27.74M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ATOS Stock Overview
- Price
- $2.78
- Previous close
- $2.56
- Open
- $2.52
- Market cap
- $27.74M
- P/E ratio
- -0.8
- 52-week range
- $1.70 - $17.25
- 1-year price target
- $17.00
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NSC
- MarketXLS Rank
- 40
About Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATOS | $2.78 | +8.6% | 235.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atossa Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW